BioStem Technologies, Inc. (BSEM)
NASDAQ: BSEM · Real-Time Price · USD
3.070
-0.020 (-0.65%)
At close: Oct 1, 2026, 4:00 PM EDT
3.110
+0.040 (1.30%)
After-hours: Oct 1, 2026, 7:30 PM EDT
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $54.8 million as of October 1, 2026.
Market Cap
54.80M
Enterprise Value
49.06M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.07
ChartMarket Cap Chart
Since August 7, 2026, BioStem Technologies's market cap has decreased from $69.50M to $54.80M, a decrease of -21.15%. That is a compound annual growth rate of -79.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 54.80M | -0.73% |
| Sep 30, 2026 | 55.20M | -19.30% |
| Sep 29, 2026 | 68.40M | -5.39% |
| Sep 28, 2026 | 72.30M | -2.17% |
| Sep 25, 2026 | 73.90M | 6.64% |
| Sep 24, 2026 | 69.30M | 2.21% |
| Sep 23, 2026 | 67.80M | -4.51% |
| Sep 22, 2026 | 71.00M | -9.55% |
| Sep 21, 2026 | 78.50M | -7.21% |
| Sep 18, 2026 | 84.60M | 8.74% |
| Sep 17, 2026 | 77.80M | 6.87% |
| Sep 16, 2026 | 72.80M | 1.68% |
| Sep 15, 2026 | 71.60M | -4.66% |
| Sep 14, 2026 | 75.10M | -2.34% |
| Sep 11, 2026 | 76.90M | 3.22% |
| Sep 10, 2026 | 74.50M | -0.80% |
| Sep 9, 2026 | 75.10M | 5.18% |
| Sep 8, 2026 | 71.40M | 7.85% |
| Sep 4, 2026 | 66.20M | 2.80% |
| Sep 3, 2026 | 64.40M | 1.90% |
| Sep 2, 2026 | 63.20M | 1.12% |
| Sep 1, 2026 | 62.50M | -4.87% |
| Aug 31, 2026 | 65.70M | 4.29% |
| Aug 28, 2026 | 63.00M | -8.30% |
| Aug 27, 2026 | 68.70M | 5.21% |
View and export this data all the way back to 2026. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 74.26M |
| Adicet Bio | 73.31M |
| Fortress Biotech | 72.04M |
| Cingulate | 71.25M |
| MAIA Biotechnology | 71.17M |
| Gain Therapeutics | 71.14M |
| OKYO Pharma | 70.85M |
| Gossamer Bio | 70.52M |